HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jimin Gao Selected Research
Jimin Gao Research Topics
Disease
40
Neoplasms (Cancer)
01/2022 - 11/2005
12
Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 06/2010
12
Prostatic Neoplasms (Prostate Cancer)
01/2020 - 07/2010
5
Lung Neoplasms (Lung Cancer)
01/2022 - 04/2014
5
Carcinogenesis
01/2020 - 01/2008
5
Infections
02/2019 - 01/2015
4
Neoplasm Metastasis (Metastasis)
01/2020 - 03/2012
3
Pneumonia (Pneumonitis)
01/2022 - 08/2015
3
Hypoxia (Hypoxemia)
11/2017 - 01/2010
2
Multiple Myeloma
01/2021 - 01/2020
2
Tuberculosis (Tuberculoses)
07/2020 - 07/2015
2
Hepatocellular Carcinoma (Hepatoma)
05/2020 - 01/2014
2
Virus Diseases (Viral Diseases)
02/2019 - 09/2015
2
Melanoma (Melanoma, Malignant)
01/2019 - 06/2006
2
Bacterial Infections (Bacterial Infection)
06/2016 - 08/2012
2
Cardiomyopathies (Cardiomyopathy)
01/2015 - 09/2010
1
Hematologic Neoplasms (Hematological Malignancy)
01/2021
1
Osteoarticular Tuberculosis
07/2020
1
Hyperthermia
05/2020
1
Insulin Resistance
01/2020
1
Communicable Diseases (Infectious Diseases)
02/2019
1
Septic Shock (Toxic Shock Syndrome)
02/2019
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2019
1
Cytokine Release Syndrome
06/2018
1
Parkinson Disease (Parkinson's Disease)
11/2017
1
Atrophy
02/2016
1
Viremia
09/2015
1
Pleural Effusion (Pleural Effusions)
07/2015
1
Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
06/2015
Drug/Important Bio-Agent (IBA)
20
Vaccines
IBA
01/2021 - 06/2006
17
Proteins (Proteins, Gene)
FDA Link
07/2020 - 06/2005
13
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
01/2021 - 06/2006
9
Streptavidin
IBA
01/2021 - 06/2006
4
Biomarkers (Surrogate Marker)
IBA
07/2020 - 02/2019
4
Antibodies
IBA
01/2020 - 01/2015
4
Cytokines
IBA
01/2020 - 08/2013
4
Biotin (Vitamin H)
FDA Link
12/2019 - 06/2006
4
Pharmaceutical Preparations
IBA
04/2019 - 01/2014
3
Carcinogens
IBA
01/2022 - 02/2009
3
Chimeric Antigen Receptors
IBA
01/2021 - 05/2020
3
Immunosorbents
IBA
07/2020 - 08/2013
3
Peptides (Polypeptides)
IBA
07/2020 - 06/2005
3
Enzymes
IBA
07/2020 - 08/2013
3
Interleukin-2 (IL2)
IBA
01/2019 - 09/2011
3
Ligands
IBA
01/2018 - 01/2014
3
Cancer Vaccines
IBA
10/2017 - 05/2011
3
Biological Products
IBA
09/2015 - 06/2012
3
Transcription Factors (Transcription Factor)
IBA
02/2014 - 01/2010
2
Therapeutic Uses
IBA
01/2022 - 10/2017
2
Paclitaxel (Taxol)
FDA Link
Generic
04/2019 - 05/2011
2
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
11/2017 - 07/2013
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
08/2015 - 07/2010
2
Cyclin D1
IBA
05/2014 - 07/2013
2
Lipocalin-2
IBA
01/2014 - 11/2013
2
arsenite
IBA
09/2013 - 01/2008
2
Ethanol (Ethyl Alcohol)
IBA
06/2012 - 07/2010
1
Benzo(a)pyrene
IBA
01/2022
1
Glycoproteins (Glycoprotein)
IBA
01/2022
1
Interleukin-7 (Interleukin 7)
IBA
01/2021
1
bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amine
IBA
01/2021
1
Complement Factor H (Factor H)
IBA
07/2020
1
Blood Proteins (Serum Proteins)
IBA
07/2020
1
Glypicans
IBA
05/2020
1
Membrane Glycoproteins (Membrane Glycoprotein)
IBA
01/2020
1
Glucose (Dextrose)
FDA Link
Generic
01/2020
1
Nonesterified Fatty Acids (NEFA)
IBA
01/2020
1
Adiponectin
IBA
01/2020
1
Fluorescent Dyes (Fluorescent Probes)
IBA
08/2019
1
C-Reactive Protein
IBA
02/2019
1
Procalcitonin
IBA
02/2019
1
human AZU1 protein
IBA
02/2019
1
Avidin
IBA
02/2019
1
Amyloid (Amyloid Fibrils)
IBA
02/2019
1
norcantharidin
IBA
07/2018
1
Combined Vaccines
IBA
01/2018
1
Immunoglobulin G (IgG)
IBA
10/2017
1
Immune Checkpoint Inhibitors
IBA
10/2017
1
Integrins
IBA
01/2017
1
Neutralizing Antibodies
IBA
01/2017
1
aspartic acid glycine arginine
IBA
01/2017
1
Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)
IBA
01/2017
1
Serum-Free Culture Media
IBA
01/2017
1
Nickel
IBA
10/2016
1
Doxorubicin (Adriamycin)
FDA Link
Generic
06/2016
1
Diacylglycerol Kinase
IBA
06/2016
1
Mechanistic Target of Rapamycin Complex 1
IBA
02/2016
1
Chemokines
IBA
02/2016
1
Sirtuin 1
IBA
09/2015
1
Catenins
IBA
09/2015
1
Complement Membrane Attack Complex (Membrane Attack Complex)
IBA
09/2015
1
poly-N-isopropylacrylamide
IBA
04/2015
1
Nucleolin
IBA
02/2015
Therapy/Procedure
15
Therapeutics
01/2021 - 05/2011
9
Immunotherapy
01/2022 - 06/2010
3
Lasers (Laser)
07/2020 - 04/2015
3
Drug Therapy (Chemotherapy)
06/2016 - 05/2011
2
Photothermal Therapy
05/2020 - 12/2017
2
Aftercare (After-Treatment)
07/2018 - 10/2017
2
Induced Hyperthermia (Thermotherapy)
12/2017 - 06/2016
1
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021